Back to top
more

Akorn, Inc. (AKRX)

(Real Time Quote from BATS)

$12.88 USD

12.88
13,663,138

-6.82 (-34.62%)

Updated Apr 23, 2018 03:48 PM ET

Add to portfolio

5-Strong Sell         5

D Value | F Growth | D Momentum | F VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Is the Options Market Predicting a Spike in Akorn (AKRX) Stock?

Investors in Akorn (AKRX) need to pay close attention to the stock based on moves in the options market lately.

AKRX

Arpita Dutt

Pharma Stock Outlook: Let's Make a Deal

M&As continue to play a major role in the pharma and biotech sector and are not showing any signs of slowing down.

UCBJF  AZN  SHPG  NVS  AGN  SNY  MRK  PFE  MNKD  GSK  PBYI  MKGAF  GERN  IONS  OSIR  OREXQ  INCY  BIIB  NVO  RHHBY  REGN  LLY  MYL  ACOR  BAYRY  ABT  ABBV  ARNA  AMGN  ALKS  ESRX  BMY  AKRX  VRX  ENDP

Arpita Dutt

Pharma Industry Outlook: M&A, Licensing Abound

Looking at consensus earnings expectations for the fourth quarter, earnings are expected to grow 16.3% and revenues 8.9%. New product sales should pick up significantly going forward.

UCBJF  AZN  SHPG  NVS  TEVA  AGN  SNY  MRK  PFE  GSK  MKGAF  INCY  ICPT  RHHBY  LLY  NVLN  MYL  ACHN  ABT  ABBV  AMGN  BMY  AKRX  VRX  ENDP

Kevin Matras

Stocks with Upgraded Broker Ratings

Kevin Matras explains why looking for stocks with upgraded broker ratings can upgrade your portfolio to a whole new level. Highlighted stocks include CAM, MU, AKRX, JLL and DTSI.

JLL  MU  AKRX

Kevin Matras

Market-Caps and Stock Selection for Maximum Gains

Small-cap stocks are often market leaders, but don't overlook the mid-caps and large-caps. See how that leadership has changed over the years and which one is in the lead now.

SIMO  SEE  ODFL  ICLR  LABL  AKRX

Brian Bolan

Bull of the Day: Akron Inc (AKRX)

A solid recent beat and a growing short position imply a good chance for a short squeeze.

AKRX

Kevin Matras

Using the Short Ratio to Forecast Turning Points

Kevin Matras looks at the 'short ratio' as a market sentiment indicator and shows how to use it for finding winning stocks. Highlighted stocks include ZINC, ENPH, AKRX, TPH and INT.

TPH  INT  AKRX  ENPH

Jared Levy

Akorn, Inc.

This small-cap pharmaceutical company has outpaced the S&P 500 by over 122% this year. They recently announced that Q4 earnings were going to exceed expectations. Akorn might be worth a look.

AKRX

Kevin Matras

Increasing Volume to Uncover Institutional Buying

Kevin Matras shows how to screen for weekly volume increases to uncover institutional buying. Highlighted stocks include AKRX, DSX, ENDP, LUV and UNH.

UNH  LUV  DSX  AKRX  ENDP

Bill Wilton

Akorn, Inc

Analysts still love AKRX.

AKRX

Bill Wilton

Akorn, Inc

AKRX is generating excellent growth both organically and through M&A activity.

AKRX